( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
242363
235558
226973
221346
Total Expenditure
193270
192594
183249
179015
PBIDT (Excl OI)
49093
42964
43724
42331
Other Income
8542
10053
9477
10665
Operating Profit
57635
53017
53201
52996
Exceptional Items
NA
NA
NA
NA
Depreciation
7285
8050
6917
6855
Profit Before Tax
46649
41311
42672
42533
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
35189
31422
32472
33315
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
35189
31422
32472
33315
Minority Interest
-198
-260
-162
-61
Shares of Associates
27
28
152
50
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
35018
31190
32462
33304
Equity Capital
20977
20974
20968
20965
Calculated EPS
3.33
2.97
3.09
3.17
Calculated EPS (Annualised)
13.35
11.89
12.38
12.70
No of Public Share Holdings
2611884898
2632733983
2866931502
2577286154
% of Public Share Holdings
24.9
25.1
27.35
24.59
PBIDTM% (Excl OI)
20.25
18.23
19.26
19.12
PBIDTM%
23.78
22.50
23.43
23.94
PBDTM%
22.25
20.95
21.84
22.31
PBTM%
19.24
17.53
18.80
19.21
PATM%
14.51
13.33
14.30
15.05